Han Gao compensation by year
Fulgent Genetics Summary Compensation Table · all 4 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Salary | $210,000 | $210,000 | $210,000 | $210,000 |
| Bonus | $0 | $0 | $0 | $8,000 |
| Stock awards | $0 | $0 | $113,400 | $0 |
| Option awards | $0 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $3,150 | $6,300 | $6,300 | $5,513 |
| Total | $213,150 | $216,300 | $329,700 | $223,513 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulgent Genetics, Inc. DEF 14A filed April 1, 2021, accession 0001564590-21-017305, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Fulgent Genetics, Inc. filed document, accession 0001564590-21-017305. Every figure is read from that document and cited to the page and table it appears in. Filed April 1, 2021.
Equity holdings
unvested awards at FY2020 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 10,313 | $537,307 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Fulgent Genetics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.
Fulgent Genetics’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Jian Xie | Chief Operating Officer | $5,908,540 |
| Paul Kim | Chief Financial Officer | $1,390,456 |
| Ming Hsieh | President and Chief Executive Officer | $248,000 |
| Han Gao · this page | Chief Scientific Officer and Laboratory Director | $223,513 |
The full Fulgent Genetics compensation record
free company briefThis page is one person within Fulgent Genetics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Fulgent Genetics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Fulgent Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.